Promoting freedom, innovation, and growth

Connect with IPI

Receive news, research, and updates

The Latest

OP/ED

How Abbott Could Introduce Regulatory Agencies to Reality

What’s surprising is that Texas — a state that has embraced a limited-government, free-market approach — still delegates and defers so much power to outdated regulatory agencies.

TECHBYTES

What 10 Million+ FCC Comments Tells Us

By making policy, instead of simply implementing and enforcing policy, the FCC has usurped the role of Congress, and people are responding accordingly.

OP/ED

When Trump Touts 'Made in America' He Should Talk Energy Too

POLICYBYTES

Lessons from the Republican Health Care Disaster

PRESS RELEASE

IPI Urges FCC Reversal of Title II Broadband Reclassification

OP/ED

Why Democrats Should Love Cruz's Health Care Amendment

Upcoming Events

September 7, 2017

Preserving a Free, Open & Innovative Internet with FCC Chairman Ajit Pai

Join us for lunch as IPI hosts one of the nation’s top policy leaders, Federal Communications Commission Chairman Ajit Pai, at our Hatton W. Sumners Distinguished Lecture Series in his first major visit to Dallas since becoming the head of the FCC.

Click here to register. 

Latest Audio


Cruz Gambles on Health Care in the Senate

IPI's Dr. Merrill Matthews discusses on 660 AM - The Answer's Mark Davis Show how Sen. Ted Cruz's amendment to the Senate healthcare reform bill and how it may be the solution to the health care stalemate.

Twitter Rant Against Local Control: Implications

A 14 tweet Twitter rant explaining the implications of accepting the argument that local control is not a sacred governing principle.

Twitter Rant Against Local Control: Theory

A 29 tweet Twitter rant explaining why I'm an opponent of local control arguments asserted by municipalities.

Great Decision from the Supreme Court of Canada overturning Canada's Harmful "Promise Doctrine"

Today the Supreme Court of Canada (SCC) issued a significant ruling overturning Canada’s harmful “Promise Doctrine,” which was a completely novel and ill-advised standard Canada has been using since 2005 to overturn patents on innovative pharmaceuticals and biologics.




  • TaxBytes-New

Copyright Institute for Policy Innovation 2017. All Rights Reserved Privacy Policy Contact IPI.

e-resources e-resources